trial

Diabetes Prevention Program in Schizophrenia [DPPS]

NCTId NCT00182494
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Unknown
Enrollment 200
Sponsored by Hamilton Health Sciences Corporation
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
200
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2005-02
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Modified diabetes prevention protocol & Metformin

Sponsors

Hamilton Health Sciences CorporationLead Sponsor
The Lawson FoundationCollaborator
Ontario Mental Health FoundationCollaborator

Investigators

1
Lakshmi P Voruganti, MDPrincipal Investigator

Sites

1 total
Hamilton, Canada

Facts & assertions

3 sourced
Enrollment
200
Phase
PHASE4
Status
UNKNOWN
relationships
The graph out of here
drug
Modified diabetes prevention protocol & Metformin
drug
lead_sponsor
Hamilton Health Sciences Corporation
company
collaborator
The Lawson Foundation
company
Ontario Mental Health Foundation
company
indication
Diabetes Mellitus
indication
Diabetes Mellitus
indication
Schizophrenia
indication
investigator
Lakshmi P Voruganti, MD
person